Express Scripts Launches New System that Predicts Prescription Habits
Express Scripts has a new tool called ScreenRx to help patients stay on their meds.
The program uses a computer to look at patient data and predicts who is most likely to forget a refill or simply stop taking their drugs.
The patient will be contacted to help them stick with their doctor’s orders.
ScreenRx detects future risk for nonadherence and tailors interventions for individual patients. Leveraging the power of predictive modeling, the tool identifies patients at highest risk for not following their doctors’ orders. Once identified, patients receive personalized interventions to help them stay on their therapy.
“ScreenRx enables Express Scripts to provide the most appropriate assistance to help each individual patient make healthier decisions, months before they might stop taking their medication,” said Steve Miller, M.D., chief medical officer at Express Scripts. “This solution brings the country one step closer to more affordable and effective care.”
ScreenRx considers more than 400 known factors about the patient, the physician, the disease and the prescribed therapy to identify who is most likely to stop taking their medication. The models are up to 98 percent accurate in predicting nonadherence one year in advance – nearly 9 times more accurate than what patients self-report.
Further, ScreenRx isolates the most likely reason why a patient is at-risk and intervenes appropriately. If a patient is likely to become nonadherent due to behavioral factors such as procrastination or forgetfulness, the patient may receive daily alerts, 90-day fills or auto-renewals. If a patient is likely to have clinical questions or concerns about the medication, the patient will receive a pharmacist consultation. If high cost is the primary concern, the patient may be contacted about payment assistance programs, lower cost medication alternatives and lower cost pharmacy options such as home delivery.